Afghanistan vs Bangladesh: Average cost of tuberculosis treatment by type
Afghanistan
10 constant 2022 US$
in 2024
Bangladesh
11 constant 2022 US$
in 2024
Afghanistan rank
50th
Bangladesh rank
48th
Average cost of tuberculosis treatment by type over time
- Afghanistan
- Bangladesh
How they compare
Bangladesh currently reports 11 constant 2022 US$ against 10 constant 2022 US$ in Afghanistan, a difference of 1 constant 2022 US$.
That makes Bangladesh's figure about 1.1 times Afghanistan's.
The two have swapped places 1 time across 6 shared years of data; in 2019 it was Afghanistan ahead.
Afghanistan ranks 50th and Bangladesh ranks 48th of 62 countries.
Across the 2 decades both report, Afghanistan averaged higher in 1 and Bangladesh in 1.
Head to head by decade
| Decade | Afghanistan | Bangladesh | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 10 constant 2022 US$ | 4 constant 2022 US$ | 6 constant 2022 US$ | Afghanistan |
| 2020s | 9 constant 2022 US$ | 13.8 constant 2022 US$ | 4.8 constant 2022 US$ | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of tuberculosis treatment by type, Afghanistan or Bangladesh?
- Bangladesh, at 11 constant 2022 US$ against 10 constant 2022 US$ in Afghanistan as of 2024.
- What is the difference in average cost of tuberculosis treatment by type between Afghanistan and Bangladesh?
- 1 constant 2022 US$, with Bangladesh ahead.
- How many years of comparable data are there for Afghanistan and Bangladesh?
- 6 years are reported by both, from 2019 to 2024.
- How do Afghanistan and Bangladesh rank globally for average cost of tuberculosis treatment by type?
- Afghanistan ranks 50th and Bangladesh ranks 48th of 62 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of tuberculosis treatment by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per person starting tuberculosis preventive treatment, excluding buffer stock.